Magnetically Functionalized Substrates for Enzymatic Activity Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for enzymatic disorders are costly and risky, lacking effective tools for monitoring enzymatic activity and disease progression in mammalian subjects.
Innovation Solution
The method involves combining magnetic particles with substrates to form magnetically functionalized substrates, which are then used in living organisms to measure changes in magnetic properties indicative of enzymatic activity, utilizing techniques like MRI to detect enzymatic activity and disease associated with enzymes such as collagenases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If magnetic particles are combined with substrates to form magnetically functionalized substrates for detecting enzymatic activity, then measurement precision and diagnostic capability are improved, but device complexity and manufacturing difficulty increase
Solution Approach 1:
Magnetic particles serve as intermediary agents that attach to substrates and enable detection of enzymatic activity through magnetic property changes. The particles act as mediators between the enzymatic reaction and the measurement system, allowing indirect detection with high precision while simplifying the overall measurement approach.
Solution Approach 2:
The method detects enzymatic activity by monitoring changes in magnetic properties (such as magnetic susceptibility, relaxation times, or signal intensity) of the magnetically functionalized substrates. These parameter changes provide a direct, measurable output that correlates with enzyme activity levels, enabling precise quantification.
2Reliability
If magnetically functionalized substrates are used for monitoring enzymatic activity in living organisms, then diagnostic capability and disease progression monitoring are improved, but ease of operation and accessibility decrease
Solution Approach 1:
The method replaces invasive mechanical or surgical diagnostic procedures with non-invasive magnetic measurements. By using magnetic resonance imaging or other magnetic detection techniques, the system can monitor enzymatic activity and disease progression without physical intervention, significantly improving ease of operation while maintaining diagnostic reliability.
3Ease of operation
If conventional diagnostic methods are used for enzymatic disorders, then ease of operation is maintained, but measurement precision and diagnostic effectiveness deteriorate
Solution Approach 1:
The magnetically functionalized substrate approach provides a universal detection method that can monitor multiple enzymatic activities and various disease conditions through a single measurement platform. This multi-functionality maintains operational simplicity while significantly enhancing diagnostic effectiveness across different clinical scenarios.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for non-invasive, cost-effective detection and monitoring of enzymatic activity and disease progression, providing actionable insights into conditions like arthritis and cancer through measurable changes in magnetic properties.
Implementation Method 1
combining at least one magnetic particle to a substrate to form a modified substrate
Implementation Method 2
The measurement may be performed by a method such as magnetic resonance imaging (MRI)
Data Source
AI summary
The present invention provides methods for detecting an enzymatic activity, the method including combining at least one magnetic particle to an enzyme substrate to form a magnetically modified substrate, reacting the magnetically modified substrate with at least one enzyme; and detecting a change in a magnetic property of the magnetically modified substrate or its cleavage products, thereby detecting an activity of said at least one enzyme, wherein the method may be applied to a human subject to detect a disease selected from the group consisting of rheumatitis, arthritis, an injury, Dupuytren's disease, Peyronie's disease, a collagen related disease, steatosis, fibrosis, cirrhosis, metastasis, tissue regeneration, cancer, coronary disease, a liver disease, a metabolic condition, an infection and an inflammatory disease.